RAC1 and melanoma: In our research, kindlin-2 was found to enhance the binding of Rac1 and α-Pix and subsequently stimulate the MAPK pathway, and the Rac1 inhibitor was proven to significantly affect the growth and, more importantly, the metastasis of melanoma both in vivo and in vitro.